Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about oxLDL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| MIR-369-3P | downregulates | gene | 0.90 |
| Succinate | upregulates | compound | 0.85 |
| miR-369-3p | downregulates | biomarker | 0.85 |
| miR_369_3p | inhibits | gene | 0.64 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| oxLDL/LOX-1/ROS Signaling Induces P2RY12 via Nrf2 Activation | 0.550 | neurodegeneration | What determines P2RY12 receptor expressi |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning oxLDL in their description or question text
No additional research found